SCHEMBL14099384

SCHEMBL14099384

c1ccc(N(c2ccccc2)c2ccc(N(c3ccccc3)c3ccccc3)c3nc4c5ccccc5c5ccccc5c4nc23)cc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.38
TDP1 Q9NUW8 3/20 0.38
MAPT P10636 5/20 0.36
LMNA P02545 2/20 0.36
POLB P06746 2/20 0.36
MEN1 O00255 1/20 0.36
PKM P14618 1/20 0.36
BLM P54132 1/20 0.36
KMT2A Q03164 1/20 0.36
L3MBTL1 Q9Y468 2/20 0.35
CYP1A2 P05177 3/20 0.34
CYP3A4 P08684 2/20 0.34
KDM4E B2RXH2 1/20 0.34
CYP2D6 P10635 1/20 0.34
CYP2C9 P11712 1/20 0.34
CYP2C19 P33261 1/20 0.34
HIF1A Q16665 2/20 0.34
TSHR P16473 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
NPC1 O15118 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14492022 0.91 MAPT (0.33) ALDH1A1TDP1MAPTLMNAPOLB
SCHEMBL14492025 0.91 MAPT (0.33) ALDH1A1TDP1MAPTLMNAPOLB
SCHEMBL14492024 0.89 MAPT (0.34) ALDH1A1TDP1MAPTLMNAPOLB
SCHEMBL14099420 0.88 SIGMAR1 (0.40) ALDH1A1TDP1MAPTLMNAL3MBTL1
SCHEMBL14099421 0.87 KDM4E (0.35) ALDH1A1TDP1MAPTLMNAL3MBTL1
SCHEMBL14099514 0.87 KDM4E (0.35) ALDH1A1TDP1MAPTLMNAL3MBTL1
SCHEMBL14492007 0.87 SLC6A2 (0.37) ALDH1A1TDP1MAPTLMNAPOLB
SCHEMBL14099377 0.86 SIGMAR1 (0.41) ALDH1A1TDP1MAPTLMNAL3MBTL1
SCHEMBL14099381 0.85 ALDH1A1 (0.35) ALDH1A1TDP1MAPTLMNAPOLB
SCHEMBL14492006 0.84 CYP11B1 (0.39) ALDH1A1TDP1MAPTLMNAPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1956011-A1 AMINE COMPOUND AND ORGANIC ELECTROLUMINESCENT ELEMENT EMPLOYING THE SAME Idemitsu Kosan Co., Ltd. (JP) 2008-08-13 EP disclosed
US-20070132372-A1 AMINE BASED COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME IDEMITSU KOSAN CO., LTD. (JP) 2007-06-14 US disclosed
US-20070132372-A1 AMINE BASED COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME IDEMITSU KOSAN CO., LTD. (JP) 2007-06-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070132372-A1 AMINE BASED COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME KCNH2, SLC7A5, KCNH3 ALDH1A1 1210/4885TDP1 2905/4885MAPT 1443/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.